• PAR5 COST-EFFECTIVENESS OF EXTENDED-RELEASE AND IMMEDIATE-RELEASE TRAMADOL FOR THE TREATMENT OF CHRONIC OSTEOARTHRITIS PAIN

    May 1, 2007, 00:00

  • PCN14 PHARMACOECONOMIC ANALYSIS OF TREATING ADVANCED GASTRIC CANCER (AGC) WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN AN ITALIAN SETTING

    May 1, 2007, 00:00

  • PMC32 SYSTEMATIC BIAS BETWEEN INTERNET AND MAIL SURVEYS- IMPLICATION FOR SCALING OF CONJOINT QUESTIONS

    May 1, 2007, 00:00

  • PCN44 INTEGRATION OF QUALITY OF LIFE WITH SURVIVAL FOR COMPARATIVE HEALTH OUTCOME ASSESSMENT

    May 1, 2007, 00:00

  • PND20 UNDERSTANDING LIMITATIONS OF PATIENT REPORTED CLINICAL OUTCOMES IN LUPUS

    May 1, 2007, 00:00

  • PGI6 BURDEN OF POST-OPERATIVE ILEUS (POI) IN COLECTOMY SURGERY PATIENTS IN THE UNITED STATES

    May 1, 2007, 00:00

  • PGI17 SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, CONCOMITANT DISEASES, HEALTH-RELATED QUALITY OF LIFE AND WORK PRODUCTIVITY-A DATABASE STUDY IN A US COHORT

    May 1, 2007, 00:00

  • PDB30 HEALTH RELATED QUALITY OF LIFE ON BODY MASS INDEX FOR PEOPLE WITH TYPE 2 DIABETES IN THE GENERAL ADULT POPULATION IN ENGLAND

    May 1, 2007, 00:00

  • PHP21 DETERMINANTS OF STATE MEDICAID PER CAPITA PRESCRIPTION DRUG EXPENDITURES-A STRUCTURE EQUATION MODELING APPROACH

    May 1, 2007, 00:00

  • PHP7 GENERIC-NAME PRESCRIPTION AND PERCEIVED QUALITY IN THE DEMAND FOR PHARMACEUTICALS IN ARGENTINA

    May 1, 2007, 00:00

  • PND25 A REVIEW OF HEALTH RELATED QUALITY OF LIFE INSTRUMENTS USED IN CHILDREN AND ADOLESCENTS WITH EPILEPSY

    May 1, 2007, 00:00

  • PCN8 COST-EFFECTIVENESS OF ANASTROZOLE VERSUS TAMOXIFEN FOR THE TREATMENT OF POST MENOPAUSAL HORMONE-RECEPTOR POSITIVE BREAST CANCER (BC) IN THE ADJUVANT SETTING IN BRAZIL

    May 1, 2007, 00:00

  • PMH32 HEALTH SERVICE AND PRESCRIPTION DRUG USE AND COSTS AMONG HISPANIC AND NON-HISPANIC CAUCASIAN SUBJECTS WITH ADHD

    May 1, 2007, 00:00

  • PND8 COST-EFFECTIVENESS OF PREGABALIN AND OTHER ADDON ANTIEPILEPTIC DRUG THERAPIES IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY IN ARGENTINA

    May 1, 2007, 00:00

  • PUK10 COST ANALYSIS OF PRE-DIALYSIS CHRONIC KIDNEY DISEASE-AN EMPLOYER'S PERSPECTIVE

    May 1, 2007, 00:00

  • PHP17 PREVALENCE OF CLINICALLY IMPORTANT POTENTIAL DRUG-DRUG INTERACTIONS IN REGIONE EMILIA ROMAGNA, ITALY

    May 1, 2007, 00:00

  • PMC7 A PRE-POST TIME IN MOTION METHODOLOGY TO EXAMINE PRODUCT WASTAGE REDUCTION- PILOT RESULTS IN MAGNETIC RESONANCE CONTRAST MEDIA PHARMACY BULK PACK

    May 1, 2007, 00:00

  • PEY16 DEPRESSIVE SYMPTOMATOLOGY, MEDICATION PERSISTENCE, AND ASSOCIATED HEALTH CARE COSTS IN OLDER ADULTS WITH GLAUCOMA

    May 1, 2007, 00:00

  • PMC15 A RETROSPECTIVE ANALYSIS OF PATIENT-REPORTED OUTCOMES AND OTHER EFFICACY ENDPOINTS IN TOP BRAND NAME PRODUCT LABELS IN UNITED STATES

    May 1, 2007, 00:00

  • PMC5 EVALUATING AN ONLINE CALCULATOR FOR ANALYZING INCREMENTAL NET BENEFIT AND THE EXPECTED VALUE OF PERFECT INFORMATION FROM PATIENT LEVEL DATA

    May 1, 2007, 00:00

  • PIN16 COST-EFFECTIVENESS ANALYSIS OF IMMUNIZATION STRATEGIES FOR THE CONTROL OF MENINGOCOCCAL INFECTIOUS DISEASE

    May 1, 2007, 00:00

  • PCV8 RISK OF MYOPATHY ASSOCIATED WITH THE USE OF STATINS AND POTENTIALLY INTERACTING MEDICATIONS— A RETROSPECTIVE ANALYSIS

    May 1, 2007, 00:00

  • CV1 IMPACT OF A TARGETED PATIENT COMMUNICATION ENCOURAGING GREATER GENERIC STATIN USE

    May 1, 2007, 00:00

  • PIN2 RETROSPECTIVE COMPARISON OF TREATMENT OUTCOMES AMONG HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON 2A OR 2B PLUS RIBAVIRIN AT DIFFERENT VA MEDICAL CENTERS

    May 1, 2007, 00:00

  • PCN35 OUTPATIENT USE OF HEMATOPOIETIC COLONY STIMULATING FACTORS (CSF) AMONG ELDERLY CANCER PATIENTS WITH CHEMOTHERAPY

    May 1, 2007, 00:00

  • PHP45 DID FDAMA SECTION 114 LEAD TO A DECLINE OF ECONOMIC-CONTENT DRUG ADVERTISING IN MEDICAL JOURNALS?

    May 1, 2007, 00:00

  • PCV52 THE IMPACT OF SIMVASTATIN LAUNCHING ON EXISTING LIPITOR PATIENTS IN A MANAGED CARE SETTING

    May 1, 2007, 00:00

  • PMH40 12-MONTH TREATMENT DISCONTINUATION RATES IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG ACTING INJECTION (RLAI)- INTERIM RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY PROJECT CONDUCTED IN SPAIN, ...

    May 1, 2007, 00:00

  • PDB29 RELATIONSHIP BETWEEN EATING HEALTHY FOODS AND REGULAR EXERCISE AND PHYSICAL HEALTH, MENTAL HEALTH, AND HEALTH STATUS IN TYPE II DIABETICS

    May 1, 2007, 00:00

  • PCASE5 APPLIED PHARMACOECONOMICS IN ACADEMIC MEDICINE- VALIDATION OF CONCEPT

    May 1, 2007, 00:00

  • PSK2 THE HEALTH CARE AND WORK LOSS COSTS ASSOCIATED WITH ATOPIC DERMATITIS

    May 1, 2007, 00:00

  • PRS3 DIRECT AND INCREMENTAL COSTS OF ACUTE RESPIRATORY INFECTIONS BY INITIATING ANTIBIOTIC

    May 1, 2007, 00:00

  • PR1 ABILITY OF SF-36 AND EQ-5D TO DISCRIMINATE AMONG DISEASE ACTIVITY LEVELS IN LUPUS

    May 1, 2007, 00:00

  • PAR11 ECONOMIC EVALUATION OF BIOLOGIC RESPONSE MODIFIER SPECIALTY PHARMACY PRIOR AUTHORIZATION PROGRAM

    May 1, 2007, 00:00

  • PMH43 SWITCHING OF ANTIPSYCHOTICS AMONG STABLE AND UNSTABLE SCHIZOPHRENIA PATIENTS

    May 1, 2007, 00:00

  • PMH14 COST-EFFECTIVENESS ANALYSIS OF GALANTAMINE (REMINYL ER) IN THE TREATMENT OF MILD TO MODERATE DEMENTIA OF THE ALZHEMIER'S TYPE IN MEXICO

    May 1, 2007, 00:00

  • PCASE2 EVALUATION OF LEVALBUTEROL USE IN A >600 BED TEACHING HOSPITAL

    May 1, 2007, 00:00

  • PCV15 NEW DIAGNOSIS OF HYPERTENSION AMONG CELECOXIB AND NON-SELECTIVE NSAID USERS-A POPULATION-BASED COHORT STUDY

    May 1, 2007, 00:00

  • PGI10 INCORPORATING NON-ADHERENCE RESULTING FROM MULTIPLE DAILY DOSE REGIMENS INTO ECONOMIC MODELS- COST-UTILITY ANALYSIS OF ALTERNATIVE GASTROINTESTINAL PROPHYLAXIS STRATEGIES IN PREVENTING NSAID ASSOCIATED GASTROINTESTINAL COMPLICATIONS I ...

    May 1, 2007, 00:00

  • PIN22 IMPACT OF S.AUREUS INFECTIONS ON EXPENDITURES AND LENGTH-OF-STAY IN U.S. HOSPITALS

    May 1, 2007, 00:00

  • PAA11 A 4-YEAR ASSESSMENT OF SUB-ACUTE LACK OF ASTHMA CONTROL IN A REAL-WORLD SETTING

    May 1, 2007, 00:00

  • PUK7 GENERIC SUBSTITUTION OF TACROLIMUS AFTER RENAL TRANSPLANTATION-A DECISION-MAKING MODEL TO WEIGH RISKS AND BENEFITS

    May 1, 2007, 00:00

  • PRS8 ASSESSING TREATMENT EFFECTS OF INHALED CORTICOSTEROID ON MEDICAL COSTS AMONG COPD PATIENTS- LONGITUDINAL ANALYSIS OF MANAGED CARE CLAIMS

    May 1, 2007, 00:00

  • Substantial Treatment Overuse in the United States?

    May 1, 2007, 00:00

  • PAA6 ECONOMIC EVALUATION OF A NEW AIRWAY INFLAMMATION MONITOR IN THE DIAGNOSIS AND MANAGEMENT OF ASTHMA IN THE US

    May 1, 2007, 00:00

  • PCASE3 USING OUTCOMES RESEARCH TO SUPPORT ANITBIOTIC SELECTION

    May 1, 2007, 00:00

  • PPN2 COGNITIVE FUNCTION IN CHRONIC NON-MALIGNANT PAIN PATIENTS TREATED WITH EXTENDED-RELEASE MORPHINE SULFATE (AVINZA®)

    May 1, 2007, 00:00

  • PCN34 ANALYSIS OF DOSE, COST AND USE PATTERNS OF ERYTHROPOIETIN STIMULATING AGENTS IN CANCER PATIENTS

    May 1, 2007, 00:00

  • PCV11 THE EFFECTS OF SEASONAL VARIATIONS AND WEATHER CONDITIONS ON THE OCCURRENCE OF HEART ATTACKS IN HUNGARY BETWEEN 2000-2004

    May 1, 2007, 00:00

  • CASE 2 COST CONTROL FOR MENTAL HEALTH

    May 1, 2007, 00:00

  • PCASE8 POLYPHARMACY MEDICATION THERAPY MANAGEMENT PROGRAM (MTMP) CASE STUDY

    May 1, 2007, 00:00

  • PHP36 GENERIC PRESCRIPTION AND PHYSICIANS QUALITY PERCEPTION IN ARGENTINA- THE EXPERIENCE OF THE REMEDIAR PROGRAM

    May 1, 2007, 00:00

  • OB4 THE RELATIONSHIP BETWEEN OBESITY AND HEALTHRELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS OR RHEUMATOID ARTHRITIS

    May 1, 2007, 00:00

  • PMH21 ANALYSIS OF DRUG TREATMENT PATTERNS, SERVICE USE AND COSTS ASSOCIATED WITH SPECIFIC PHARMACOLOGICAL TREATMENTS FOR MAJOR DEPRSSIVE DISORDER

    May 1, 2007, 00:00

  • PAR4 ECONOMIC EVALUATION OF TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF ANKYLOSING SPONDYLITIS

    May 1, 2007, 00:00

  • PCN28 A MARKOV MODEL EVALUATING THE COST-UTILITY OF A 4D REAL-TIME ELECTROMAGNETIC TRACKING SYSTEM (CALYPSO® 4D LOCALIZATION SYSTEM WITH BEACON TRANSPONDERS) IN THE LOCALIZATION OF PROSTATE TUMORS DURING RADIOTHERAPY

    May 1, 2007, 00:00

  • PEY9 EFFECTIVENESS AND COSTS OF TRAVATAN VS XALACOM AS FIRST-LINE TREATMENT FOR GLAUCOMA-AN ANALYSIS PERFORMED ON THE UK GENERAL PRACTITIONER RESEARCH DATABASE

    May 1, 2007, 00:00

  • PND31 THE IMPACT OF CHRONIC INSOMNIA ON PRODUCTIVITY IN THE US, FRANCE, AND JAPAN

    May 1, 2007, 00:00

  • CN1 A COST—EFFECTIVENESS ANALYSIS MODEL FOR THE SECOND LINE TREATMENT OF GASTROINTESTINAL STROMAL TUMOURS (GIST) IN MEXICO

    May 1, 2007, 00:00

  • PUK6 IMPACT OF AN INCREMENTAL INCREASE IN PERITONEAL DIALYSIS UTILIZATION ON HOSPITAL BUDGETS IN COLOMBIA- USE OF A BUDGET IMPACT MODEL

    May 1, 2007, 00:00

  • PUK13 PANEL DATA ANALYSIS SHOWS PERITONEAL DIALYSIS TO BE NEGATIVELY ASSOCIATED WITH HOSPITALIZATION AT THE STATE LEVEL

    May 1, 2007, 00:00

  • PPN6 A COST MINIMIZATION ANALYSIS OF IV BOLUS VERSUS IV INFUSION DICLOFENAC IN POST-OPERATIVE PAIN

    May 1, 2007, 00:00

  • NE1 EMPLOYEES WITH FIBROMYALGIA- MEDICAL COMORBIDITY, HEALTH CARE COSTS, AND WORK LOSS

    May 1, 2007, 00:00

  • PAR14 UTILIZATION OF CHRONIC ARTHRITIS-RELATED HEALTH CARE SERVICES BY CHILDREN AND ADOLESCENTS IN A MEDICAID POPULATION

    May 1, 2007, 00:00

  • PGI13 LOWER DISEASE ACTIVITY AND CLINICAL REMISSION ARE ASSOCIATED WITH REDUCED HOSPITALIZATION RISK IN CROHN'S DISEASE

    May 1, 2007, 00:00

  • PQ3 A DECISION TREE APPROACH TO ESTIMATING COST SAVINGS OF PAY FOR PERFORMANCE PROGRAMS IN A PPO SETTING

    May 1, 2007, 00:00

  • PCN42 A MULTI-PART EVALUATION OF A CANCER SYMPTOM MANAGEMENT INFORMATION TECHNOLOGY SYSTEM

    May 1, 2007, 00:00

  • PCV60 THE CLIN-O-GRAM-A GRAPHICAL TOOL DESCRIBING DRUG USE PRIOR TO CLINICAL OUTCOMES

    May 1, 2007, 00:00

  • PAR10 MANAGEMENT OF RHEUMATOID ARTHRITIS—FINDINGS FORM A CLAIMS DATABASE ANALYSIS

    May 1, 2007, 00:00

  • PIN4 TREATMENT FAILURE AMONG COMMUNITY ACQUIRED PNEUMONIA (CAP) PATIENTS TREATED WITH LEVOFLOXACIN OR MACROLIDES IN AN OUTPATIENT SETTING

    May 1, 2007, 00:00

  • PDB34 EFFECT OF INSULIN GLARGINE AND NPH INSULIN ON QUALITY OF LIFE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2007, 00:00

  • CASE 4 IMPLEMENTATION AND EVALUATION OF AN EVIDENCE-BASED CONTINUUM FOR HIP AND KNEE REPLACEMENTS IN ALBERTA

    May 1, 2007, 00:00

  • PDB36 DIFFERENCES IN EQ-5D SCORES FOR US AND UK-BASED PREFERENCE SCORING SYSTEMS IN PEOPLE WITH TYPE 2 DIABETES MELLITUS

    May 1, 2007, 00:00

  • PIN21 THE CLINICAL AND ECONOMIC BURDEN OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS DUE TO STAPHYLOCOCCUS AUREUS- FINDINGS FROM A NATIONAL DATABASE

    May 1, 2007, 00:00

  • PCV71 THE IMPACT OF INTERACTIVE VOICE RECOGNITION TECHNOLOGY ON ADHERENCE TO STATIN THERAPY

    May 1, 2007, 00:00

  • PCV5 NON-PERSISTENT USE OF ANTIHYPERTENSIVE DRUGS INCREASES RISK OF HOSPITALIZATIONS FOR STROKE BY NEARLY 20%

    May 1, 2007, 00:00

  • PMC9 DEVELOPMENT OF PHARMACOECONOMIC ANALYSIS IN THE RUSSIAN FEDERATION

    May 1, 2007, 00:00

  • PCV70 MOBILE PHONE MESSAGE VERSUS POSTAL REMINDERS TO INCREASE TREATMENT ADHERENCE AFTER LIPID LOWERING THERAPY AMONG HYPERLIPIDEMIC PATIENTS IN PRIMARY CARE

    May 1, 2007, 00:00

  • PIN12 THE COST-EFFECTIVENESS ANALYSIS OF ENTECAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B (CHB) PATIENTS IN POLAND

    May 1, 2007, 00:00

  • PEY11 COST OF STANDARD CARE TREATMENT IN PATIENTS WITH PROGRESSION OF PRIMARY OPEN ANGLE GLAUCOMA

    May 1, 2007, 00:00

  • MD3 CHANGES IN PRESCRIPTION USE AND OUT-OF POCKET COSTSAMONG MEDICARE ELIGIBLE ADULTS, 2005-2006

    May 1, 2007, 00:00

  • PCV27 CLINICAL AND ECONOMIC BURDEN OF NONADHERANCE TO LIPID-LOWERING AND ANTIHYPERTENSIVE THERAPY IN A HYPERTENSIVE POPULATION

    May 1, 2007, 00:00

  • PHM9 THE ASSOCIATION OF BARRIERS TO CARE AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH FACTOR VIII DEFICIENCY-THE HEMOPHILIA UTILIZATION GROUP STUDYPART V (HUGS-V)

    May 1, 2007, 00:00

  • Mapping from Disease-Specific Measures to Utility- An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility

    May 1, 2007, 00:00

  • PMH37 TREATMENT PERSISTENCE AND COMPLIANCE WITH GALANTAMINE ER

    May 1, 2007, 00:00

  • PCN50 CHALLENGES AND LIMITATIONS OF IDENTIFYING PRESCRIPTION TREATMENT PATTERNS FOR PATIENTS WITH METASTATIC BREAST CANCER USING COMMERCIALLY INSURED CLAIMS DATABASES

    May 1, 2007, 00:00

  • PIN18 PHARMACOECONOMIC EVALUATION OF HERD IMMUNITY CONFERRED BY SEVEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PREVNAR®) IN CANADA BASED ON CALGARY REGION EPIDEMIOLOGICAL DATA

    May 1, 2007, 00:00

  • PHP19 RACE AND ASSOCIATED MEDICATION ADHERENCE IN MEDICAID ENROLLED PATIENTS WITH CHRONIC DISEASE

    May 1, 2007, 00:00

  • PCV68 IS META-ANALYSIS ALWAYS A GOOD IDEA?

    May 1, 2007, 00:00

  • PND23 PSYCHOMETRIC EVALUATION OF FIVE MIGRAINE SPECIFIC HEALTH RELATED QUALITY OF LIFE INSTRUMENTS

    May 1, 2007, 00:00

  • PHP41 PHYSICIANS' ATTITUDES TOWARD E-DETAILING- (A PILOT STUDY)

    May 1, 2007, 00:00

  • PMC18 USE OF PRO INSTRUMENTS- COPYRIGHT ISSUES

    May 1, 2007, 00:00

  • PHP43 ANALYSIS OF COMMUNITY PHARMACISTS' INTERVENTIONS ON ELECTRONIC PRESCRIPTION ERRORS

    May 1, 2007, 00:00

  • Abstracts Index

    May 1, 2007, 00:00

  • PMH16 PREDICTORS OF HIGH COSTS FOR GENERALIZED ANXIETY DISORDER WITH OR WITHOUT PAIN

    May 1, 2007, 00:00

  • PDB27 MEDICATION ADHERENCE IN PATIENTS WITH DIABETES DURING THE MEDICARE PART D BENEFIT COVERAGE GAP PERIOD

    May 1, 2007, 00:00

  • PMH13 COST-EFFECTIVENESS ANALYSIS OF SINGLE-DOSE EXTENDED RELEASE METHYLPHENIDATE (CONCERTA®) VS. ATOMOXETINE AND SHORT-ACTION METHYLPHENIDATE, FOR THE MANAGEMENT OF ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY IN MEXICO

    May 1, 2007, 00:00

  • PAA17 PARENTS OF ASTHMATIC CHILDREN WERE ACCURATE REPORTERS OF URGENT HEALTH SERVICES USE— A RETROSPECTIVE AGREEMENT ANALYSIS

    May 1, 2007, 00:00

  • PDB26 CAN PATIENTS ACCURATELY RATE THEIR ADHERENCE TO MEDICATIONS?

    May 1, 2007, 00:00

  • AR2 THE ASSOCIATION BETWEEN CO-EXISTING IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) AND HEALTH CARE COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WHO RECEIVED ANTI-TUMOR NECROSIS FACTORS (ANTI-TNFS)

    May 1, 2007, 00:00

  • PMH29 ECONOMIC BURDEN OF ALCOHOLISM AND ALCOHOL ABUSE IN A US MANAGED-CARE SETTING

    May 1, 2007, 00:00

  • PCN39 GAP BETWEEN INPATIENT TREATMENT COST OF AND MORTALITY DUE TO BREAST CANCER IN HUNGARY

    May 1, 2007, 00:00

  • POI6 WOMEN TREATED WITH MONTHLY IBANDRONATE DEMONSTRATE IMPROVED PERSISTENCE VERSUS WEEKLY BISPHOSPHONATES

    May 1, 2007, 00:00

  • PHM4 THE ASSOCIATION BETWEEN CONCOMITANT MEDICATIONS USE AND THROMBOEMBOLIC COMPLICATIONS IN ELDERLY VETERANS UNDERGOING MAJOR ORTHOPEDIC SURGERY

    May 1, 2007, 00:00

  • PIN17 COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION (PCV) FOR INFANTS WITH THE 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HONG KONG

    May 1, 2007, 00:00

  • PCN18 BURDEN OF ILLNESS ANALYSIS OF MALIGNANT METASTATIC MELANOMA IN THE UNITED STATES

    May 1, 2007, 00:00

  • PRS4 AN ECONOMIC EVALUATION OF FIRST LINE ANTIBIOTICS FOR THE INPATIENT TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS IN MEXICO

    May 1, 2007, 00:00

  • PMH25 PREDICTORS OF BIPOLAR DISORDER IN PATIENTS DIAGNOSED WITH MAJOR DEPRESSION IN A PRIVATELY INSURED POPULATION

    May 1, 2007, 00:00

  • PEY10 COST OF BLINDNESS IN THE CZECH REPUBLIC

    May 1, 2007, 00:00

  • PMH33 PROFILING UTILIZATION PATTERNS OF ANTIPSYCHOTICS AMONG PATIENTS WITH BIPOLAR DISORDER-A CLAIMS DATA ANALYSIS

    May 1, 2007, 00:00

  • CN3 60-MONTH DATA FROM IRIS USED TO UPDATE ESTIMATES OF SURVIVAL AND COST-EFFECTIVENESS OF FIRST-LINE IMATINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

    May 1, 2007, 00:00

  • PAA26 SOCIOECONOMIC FACTORS RELATED TO ASTHMA CONTROL IN CHILDREN

    May 1, 2007, 00:00

  • CASE 6 INCORPORATION OF COST EFFECTIVENESS FOR FORMULARY ADDITIONS AT A CANCER CENTER

    May 1, 2007, 00:00

  • PMC23 CONSISTENCY OF MINIMAL IMPORTANT DIFFERENCES FOR MAPPED UTILITY INSTRUMENTS IN FOUR MAJOR PATIENT GROUPS

    May 1, 2007, 00:00

  • PMC4 DEVELOPING NATIONS AND COST-EFFECTIVENESS- THE METHODS MATTER

    May 1, 2007, 00:00

  • PEY15 THE IMPACT OF PHARMACOTHERAPY COMPLIANCE ON HEALTH CARE CHARGES IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA

    May 1, 2007, 00:00

  • PAA4 ADVERSE DRUG REACTIONS IN ECONOMIC EVALUATIONS

    May 1, 2007, 00:00

  • PPN17 QUANTIFYING HEALTH RELATED QUALITY OF LIFE IN A CHRONIC PAIN POPULATION- PRELIMINARY RESULTS

    May 1, 2007, 00:00

  • RS3 THE HEALTH STATUS BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN A U.S. MEDICARE POPULATION- FINDINGS FROM THE MEDICARE CURRENT BENEFICIARY SURVEY

    May 1, 2007, 00:00

  • PND7 PHARMACOECONOMIC ANALYSIS OF ANTIEPILEPTIC DRUGS IN THE TREATMENT OF THE IDIOPATHIC GENERALIZED EPILEPSIES

    May 1, 2007, 00:00

  • PND12 IMPACT OF RELAPSES ON TOTAL COSTS OF CARE FOR PATIENTS WITH MULTIPLE SCLEROSIS

    May 1, 2007, 00:00

  • PAA9 A 4-YEAR ASSESSMENT OF SEVERE AND NON-SEVERE ASTHMA IN A REAL-WORLD SETTING

    May 1, 2007, 00:00

  • PSU2 COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN THE TREATMENT OF OPEN TIBIA FRACTURES IN SWEDEN AND DENMARK

    May 1, 2007, 00:00

  • PCV14 SURVIVAL ANALYSIS OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ACCORDING TO HOSPITAL TYPE

    May 1, 2007, 00:00

  • PAR18 A FIVE-YEAR LONGITUDINAL ANALYSIS COMPARING DOSE CHANGES FOR PATIENTS WITH RHEUMATOID ARTHRITIS TAKING INFLIXIMAB IN A MEDICARE AND IN A COMMERCIALLY INSURED POPULATION

    May 1, 2007, 00:00

  • PDB17 DETERMINATION OF HEALTH CARE COSTS INCURRED BY SWEDISH PATIENTS WITH TYPE 2 DIABETES

    May 1, 2007, 00:00

  • PDB35 ESTIMATING HEALTH-RELATED QUALITY OF LIFE FROM HYPOGLYCEMIA ELICITED FROM NON-DIABETIC AND DIABETIC RESPONDENTS IN CANADA

    May 1, 2007, 00:00

  • PIH12 IDENTIFYING MEANINGFUL IMPROVEMENTS IN VASOMOTOR SYMPTOMS AMONG MENOPAUSAL WOMEN USING DESVENLAFAXINE SUCCINATE

    May 1, 2007, 00:00

  • PCV48 IMPACT OF MEDICAID PREFERRED DRUG LISTS ON THERAPEUTIC ADHERENCE

    May 1, 2007, 00:00

  • PUK4 HAEMOGLOBIN FLUCTUATIONS IN HAEMODIALYSIS PATIENTS RECEIVING INTRAVENOUS EPOETIN ALFA OR INTRAVENOUS DARBEPOETIN ALFA

    May 1, 2007, 00:00

  • PCV21 ECONOMIC EVALUATION OF EPLERENONE COMPARED WITH PLACEBO IN PATIENTS WITH MYOCARDIAL INFARCTION COMPLICATED BY LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AND HEART FAILURE IN MEXICO

    May 1, 2007, 00:00

  • PND11 LIFETIME CLINICAL AND ECONOMIC CONSEQUENCES OF CHANGES IN BODY WEIGHT ASSOCIATED WITH MIGRAINE HEADACHE PROPHYLAXIS WITH TOPIRAMATE VERSUS AMITRIPTYLINE

    May 1, 2007, 00:00

  • PRS5 COST—EFFECTIVENESS ANALYSIS OF FIRST LINE ANTIBIOTICS FOR THE INPATIENT TREATMENT OF PATIENTS WITH COMMUNITY ACQUIRE PNEUMONIA IN A PUBLIC MEXICAN HOSPITAL

    May 1, 2007, 00:00

  • PUK1 A RETROSPECTIVE COMPARATIVE ANALYSIS OF TREATMENT OUTCOMES OF ALPHA-BLOCKERS IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA WITHIN A MANAGED CARE POPULATION

    May 1, 2007, 00:00

  • PMC33 PHARMACOECONOMICS IN THE HEALTH CARE SYSTEM IN GAUTENG PROVINCE

    May 1, 2007, 00:00

  • PGI12 HAVING YOUR CAKE AND EATING IT TOO- RESULTS FROM A POLICY ANALYSIS OF A PROTON PUMP INHIBITOR PREFERRED DRUG LIST

    May 1, 2007, 00:00

  • PIH1 EVALUATION OF CAUSES AND CONSEQUENCES OF INJURIES IN CHILDREN

    May 1, 2007, 00:00

  • PST1 EPIDEMIOLOGY AND ECONOMIC BURDEN OF STROKE-RELATED RISK FACTORS-A SYSTEMATIC LITERATURE REVIEW

    May 1, 2007, 00:00

  • PAR8 NEW AUDIENCE FOR PATIENT-REPORTED OUTCOMES (PRO) DATA- PATIENTS

    May 1, 2007, 00:00

  • PUK17 STRESS URINARY INCONTINENCE- EFFECT OF OBESITY IN PATIENTS' PERCEPTION OF HEALTH RELATED QUALITY OF LIFE

    May 1, 2007, 00:00

  • PCV24 USE OF A DECISION ANALYTIC MODEL TO EVALUATE COST PER PATIENT TREATED TO GOAL WITH HIGH POTENCY ANTILIPIDEMICS

    May 1, 2007, 00:00

  • PRS9 ESTIMATED COST SAVINGS ASSOCIATED WITH THE USE OF A NEW TASTE-MASKED ORAL CLARITHROMYCIN PREPARATION FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS IN CHILDREN IN GERMANY

    May 1, 2007, 00:00

  • PDB14 ECONOMIC OUTCOMES ASSOCIATED WITH SWITCHING TO INSULIN PEN THERAPY IN MEDICAID TYPE 2 DIABETES PATIENTS- A RETROSPECTIVE DATABASE ANALYSIS

    May 1, 2007, 00:00

  • PGI5 PHARMACOECONOMICS OF CHRONIC HEPATITIS C IN SLOVAKIA

    May 1, 2007, 00:00

  • PAA20 IMPACT OF ADHERENCE TO INHALED CORTICOSTEROID ON HEALTH CARE UTILIZATION

    May 1, 2007, 00:00

  • PDB15 TREATMENT COSTS ATTRIBUTABLE TO OVERWEIGHT/OBESE IN PATIENTS WITH DIABETES MELLITUS IN THE U.S.ADULT POPULATION

    May 1, 2007, 00:00

  • PPN8 OUT-OF-POCKET PRICES OF OPIOID ANALGESICS IN THE UNITED STATES

    May 1, 2007, 00:00

  • PQ2 COMPLIANCE AND PERSISTENCE WITH ASTHMA MEDICATIONS- IMPLICATIONS OF ASTHMA SEVERITY

    May 1, 2007, 00:00

  • PCN12 COLORECTAL CANCER- COST-EFFECTIVENESS OF SCREENING AND CHEMOPREVENTION IN AVERAGE RISK MALES

    May 1, 2007, 00:00

  • PND19 DEVELOPING A MIGRAINE QUALITY OF CARE MEASUREMENT SET

    May 1, 2007, 00:00

  • PMC20 CROSS-OVER RANDOMIZED CONTROL TRIAL OF ELECTRONIC MEASUREMENT OF HEALTH-RELATED QUALOITY OF LIFE IN CHINA

    May 1, 2007, 00:00

  • PRS10 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)- HOSPITALIZATIONS AND COSTS BY SEVERITY OF ILLNESS

    May 1, 2007, 00:00

  • NE2 IMPACT OF PATIENT COMORBIDITIES ON PHARMACOLOGICAL TREATMENT OF INSOMNIA-AN ANALYSIS OF THE NATIONAL AMBULATORY MEDICAL CARE SURVEY DATA- 1995-2004

    May 1, 2007, 00:00

  • PHP6 CHARACTERISTICS OF PATIENTS RECEIVING PHARMACEUTICAL SAMPLES AND ASSOCIATION BETWEEN SAMPLE USE AND OUT-OF-POCKET PRESCRIPTION COSTS

    May 1, 2007, 00:00

  • PCV74 DEVELOPMENT AND VALIDATION OF THE HEALTH-RELATED QUALITY OF LIFE (HRQL) COMPONENT OF THE HYBRID INSTRUMENT-IMPACT (IMPACT OF PHARMACIST ACTIVITIES AND CARE ON TREATMENT OUTCOMES)

    May 1, 2007, 00:00

  • PSK1 COST EFFECTIVENESS OF THE USE OF INFLIXIMAB COMPARED TO OTHER BIOLOGICAL AGENTS (BA) IN THE SYSTEMIC TREATMENT OF MODERATE TO SEVERE PSORIASIS

    May 1, 2007, 00:00

  • PGI8 COST OF PATIENT CARE IN PATIENTS WITH CROHN'S DISEASE IN BRAZIL- PUBLIC HEALTH PERSPECTIVE

    May 1, 2007, 00:00

  • PCN30 A COST—UTILITY ANALYSIS MODEL FOR THE SECOND LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO

    May 1, 2007, 00:00

  • PCN22 FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES

    May 1, 2007, 00:00

  • PMH10 COST-EFFECTIVINESS ANALYSIS OF LONG ACTING MICROSPHERES OF RISPERIDONE (RISPERDAL CONSTA) IN THE TREATMENT OF SCHIZOPHRENIA IN MEXICO

    May 1, 2007, 00:00

  • CV4 THE IMPACT OF A CALCIUM CHANNEL BLOCKER PREFERRED DRUG LIST ON MEDICAID PRESCRIPTION EXPENDITURES AND UTILIZATION

    May 1, 2007, 00:00

  • PAA7 PHARMACOECONOMIC OUTCOMES OF LEVALBUTEROL AND RACEMIC ALBUTEROL IN HOSPITALIZED PATIENTS REQUIRING NEBULIZATION THERAPY (POLARIS)

    May 1, 2007, 00:00

  • PCV12 SEASONAL VARIATIONS OF THE OCCURRENCE OF ACUTE MYOCARDIAL INFARCTION IN HUNGARY BETWEEN 2000-2004

    May 1, 2007, 00:00

  • PCV65 DRUG-DRUG INTERACTIONS ON ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR PRESCRIPTIONS IN THE UNITED STATES- 2001 TO 2004

    May 1, 2007, 00:00

  • PIN15 COST EFFECTIVENESS OF MF59 ADJUVANTED INFLUENZA VACCINE IN FRANCE

    May 1, 2007, 00:00

  • PMH42 IMPACT OF ALTERNATIVE CENSORING SPECIFICATIONS ON TIME-TO-EVENT ANALYSES COMPARING ALTERNATIVE MEDICATIONS

    May 1, 2007, 00:00

  • RS1 COST EFFECTIVENESS OF QUANTIFERON IN SCREENING FOR TUBERCULOSIS INFECTION IN CLOSE CONTACTS IN JAPAN

    May 1, 2007, 00:00

  • PCN25 REAL-WORLD EPOETIN ALFA (EPO) AND DARBEPOETIN ALFA (DARB) DOSING AND COST CONSIDERATIONS IN ELDERLY HOSPITAL INPATIENTS- RESULTS FROM A LARGE OBSERVATIONAL STUDY

    May 1, 2007, 00:00

  • PMH27 STIMULANT UTILIZATION IN CHILDREN UNDER A STATE EMPLOYEES BENEFIT PROGRAM

    May 1, 2007, 00:00

  • PMH26 ACCESS TO ILLICT DRUGS- POLICY IMPLICATIONS FROM THE 2003 NATIONAL SURVEY

    May 1, 2007, 00:00

  • PND2 SAFETY AND IMMUNOGENICITY OF REBIF® NEW FORMULATION (RNF) A NEW SUBCUTANEOUS FORMULATION OF INTERFERON BETA-1A 44 MCG THREE TIMES WEEKLY- 1-YEAR RESULTS OF A PHASE IIIB STUDY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

    May 1, 2007, 00:00

  • PGI2 BIOLOGICAL AGENTS FOR THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS-A SYSTEMATIC REVIEW, META-ANALYSIS AND MULTIPLE TREATMENT COMPARISON

    May 1, 2007, 00:00

  • POI8 CAN THE SF-36 PHYSICAL FUNCTION SCALE CAPTURE FUNCTIONAL OUTCOMES DURING RECOVERY FROM TRAUMATIC INJURY? A REVIEW OF THE LITERATURE

    May 1, 2007, 00:00

  • IN4 ECONOMIC EVALUATION OF INFLUENZA PANDEMIC MITIGATION STRATEGIES IN THE US USING A STOCHASTIC MICROSIMULATION INFLUENZA MODEL

    May 1, 2007, 00:00

  • PST5 PROMOTING THE IMPROVEMENT OF STROKE CARE AT THE STATE-LEVEL- CREATING A LEGISLATIVE POLICY REPORT LINKED TO AN EVIDENCE-BASED SIMULATION MODEL

    May 1, 2007, 00:00

  • PPN1 SURVEY OF CHRONIC PAIN IN TURKEY

    May 1, 2007, 00:00

  • PCV66 MODELED ACHIEVEMENT OF OPTIMAL LIPID VALUES AND ASSOCIATED CARDIOVASCULAR EVENT RATES WITH EXTENDED-RELEASE NIACIN/SIMVASTATIN, EZETIMIBE/SIMVASTATIN, AND INDIVIDUAL AGENTS IN A MANAGED CARE POPULATION

    May 1, 2007, 00:00

  • PCASE6 CLINICAL OUTCOMES ASSESSMENT IN BEHAVIORAL HEALTH CARE- SEARCHING FOR PRACTICAL SOLUTIONS

    May 1, 2007, 00:00

  • PIH3 COST-EFFECTIVENESS OF ORAL AND TRANSDERMAL CONTRACEPTIVE METHODS

    May 1, 2007, 00:00

  • PUK3 RISK FACTORS ASSOCIATED WITH MEDICATION NONADHERENCE AMONG RENAL TRANSPLANT RECIPIENTS

    May 1, 2007, 00:00

  • PHP44 PHARMACIST WORKLOAD AND PHARMACY CHARACTERISTICS ASSOCIATED WITH THE DISPENSING OF POTENTIALLY CLINICALLY IMPORTANT DRUG-DRUG INTERACTIONS

    May 1, 2007, 00:00

  • PMC19 HOW GOOD IS GOOD ENOUGH? INTERNAL VALIDITY OF STATED PREFERENCES FOR DRUG THERAPIES

    May 1, 2007, 00:00

  • PEY12 IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE ON ACUTE OTITIS MEDIA IN YOUNG CHILDREN IN THE UNITED STATES, 1997–2004

    May 1, 2007, 00:00

  • IN3 THE ECONOMIC BURDEN OF VENTILATOR-ASSOCIATED PNEUMONIA DUE TO STAPHYLOCOCCUS AUREUS- FINDINGS FROM A NATIONAL DATABASE

    May 1, 2007, 00:00

  • PUK5 FLUCTUATIONS IN HAEMOGLOBIN LEVELS IN PREDIALYSIS AND PERITONEAL DIALYSIS PATIENTS RECEIVING INTRAVENOUS EPOETIN ALFA OR INTRAVENOUS DARBEPOETIN ALFA

    May 1, 2007, 00:00

  • PHP32 THE STATE OF HEALTH STATUS MEASUREMENT IN LATIN AMERICA

    May 1, 2007, 00:00

  • DB1 IMPACT OF MAJOR PHARMACY BENEFIT CHANGE ON DIABETES DRUG UTILIZATION

    May 1, 2007, 00:00

  • PCV35 IMPACT OF NESIRITIDE ON TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE (ADHF)- EVIDENCE FROM A US HOSPITAL DATABASE

    May 1, 2007, 00:00

  • PND13 HEALTH CARE COSTS AND UTILIZATION FOR ALZHEIMER'S DISEASE PATIENTS

    May 1, 2007, 00:00

  • WH3 REDUCED WORK LIMITATION WITH IMPROVEMENT IN MOOD, SLEEP AND VASOMOTOR SYMPTOMS IN POSTMENOPAUSAL WOMEN

    May 1, 2007, 00:00

  • PCV75 LINGUISTIC VALIDATION OF THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE IN 30 LANGUAGES

    May 1, 2007, 00:00

  • PHP10 ASSESSING PAYER AND EMPLOYER PERSPECTIVES RELATED TO VALUE IN HEALTH CARE

    May 1, 2007, 00:00

  • PCN46 ESTIMATING THE NUMBER NEEDED TO VACCINATE FROM A MARKOV MODEL OF GENITAL WARTS, CERVICAL PRECANCER AND CANCER

    May 1, 2007, 00:00

  • PHP20 IMPACT OF POLYPHARMACY MEDICATION THERAPY MANAGEMENT PROGRAM (MTMP) ON DRUG EXPENDITURES IN MEDICARE PART D POPULATION

    May 1, 2007, 00:00

  • PCV16 AN ECONOMIC ASSESSMENT OF THE CONTROL AND DETENTION PROGRAMS IN HYPERTENSIVE MEXICAN POPULATION (2005-2025)

    May 1, 2007, 00:00

  • PAA15 AGREEMENT BETWEEN PARENT REPORTS AND MEDICAL CHARTS FOR PEDIATRIC ASTHMA MEDICATION UTILIZATION

    May 1, 2007, 00:00

  • PDB32 HEALTH-RELATED QUALITY OF LIFE AND UTILITIES OF RESPONDENTS WITH TYPE 2 DIABETES COMPARED TO THOSE WITH DIFFERING LEVELS OF CARDIOMETABOLIC RISK

    May 1, 2007, 00:00

  • PEN1 ESTIMATING THE QALY BENEFITS OF TREATMENT FOR GROWTH HORMONE DEFICIENCY (GHD) IN ADULT PATIENTS-A PRECURSOR TO COST-EFFECTIVENESS ANALYSIS

    May 1, 2007, 00:00

  • PCV28 A COST-EFFECTIVENESS ANALYSIS FOR PROPHYLACTIC THERAPIES AGAINST AIR TRAVELER THROMBOSIS

    May 1, 2007, 00:00

  • PCN47 EVALUATION OF FACTOR STRUCTURE AND RELIABILITY OF THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY—KIDNEY SYMPTOM INDEX

    May 1, 2007, 00:00

  • PAR6 A COMPARISON OF HEALTH CARE COSTS IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) WHO RECEIVED ETANERCEPT (ETA), ETA PLUS METHOTREXATE (MTX), INFLIXIMAB (INF), OR INF PLUS MTX

    May 1, 2007, 00:00

  • AR3 CAUSES AND EFFECTS OF SCENARIO REJECTION- STATED PREFERENCES FOR RHEUMATOID ARTHRITIS TREATMENTS

    May 1, 2007, 00:00

  • PIN31 PATTERNS OF ANTIVIRAL THERAPY USE AMONG CHRONIC HEPATITIS C PATIENTS ENROLLED IN MEDICAID

    May 1, 2007, 00:00

  • AO3 PERSISTENT USE OF ANTIHYPERTENSIVE DRUGS LEADS TO A 1.5-2 TIMES INCREASED CHANCE OF BLOOD PRESSURE GOAL ATTAINMENT IN STAGE 2 ANTIHYPERTENSIVE PATIENTS

    May 1, 2007, 00:00

  • PUK20 IMPACT OF SOLIFENACIN ON QUALITY OF LIFE, MEDICAL CARE USE, WORK PRODUCTIVITY, AND HEALTH UTILITY IN THE ELDERLY

    May 1, 2007, 00:00

  • PMC14 PREDICTORS OF SELF-RATED HEALTH STATUS AMONG GENERAL POPULATION IN THE UNITED STATES USING THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS)

    May 1, 2007, 00:00

  • PMH24 36-MONTH COST-UTILITY ANALYSIS OF ANTIPSYCHOTIC TREATMENTS IN PATIENTS WITH SCHIZOPHRENIA IN THE PAN-EUROPEAN SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY

    May 1, 2007, 00:00

  • PUK16 ASSESSMENT OF ADHERENCE WITH IMMUNOSUPPRESSANT MEDICATIONS IN TRANSPLANT PATIENTS AND THE POTENTIAL COST SAVINGS ASSOCIATED WITH INCREASED ADHERENCE

    May 1, 2007, 00:00

  • PIN26 IMPACT OF HIV AND HCV CO-INFECTION ON HOSPITALIZATION AND RESOURCE USE AMONG HEMOPHILIA ENROLLEES IN COMMERCIAL HEALTH PLANS

    May 1, 2007, 00:00

  • PCASE1 APPLICATION OF PHARMACOECONOMICS TO DOD'S ANTILIPIDEMIC-1 UNIFORM FORMULARY DECISION

    May 1, 2007, 00:00

  • PMH47 THE EFFECTS OF PATIENT TYPE ON PHYSICAL AND MENTAL HEALTH OF CAREGIVERS IN FRANCE, GERMANY, ITALY, SPAIN AND THE UNITED KINGDOM

    May 1, 2007, 00:00

  • PPN3 ESTIMATED COSTS ASSOCIATED WITH DIFFERENT FRACTURE RISKS RELATED TO OPIOID TREATMENT IN GERMANY

    May 1, 2007, 00:00

  • PMH17 TREATMENT COSTS OF COMORBID GENERALIZED ANXIETY DISORDER, DEPRESSION AND PAIN

    May 1, 2007, 00:00

  • PMH23 ECONOMIC EVALUATION OF LONG ACTING TREATMENTS FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER IN THE MILITARY HEALTH SYSTEM

    May 1, 2007, 00:00

  • PCN9 PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA WITH PEGFILGRASTIM IS COST-EFFECTIVE COMPARED WITH SECONDARY PROPHYLAXIS FOR WOMEN WITH EARLYSTAGE BREAST CANCER RECEIVING CHEMOTHERAPY

    May 1, 2007, 00:00

  • PEY7 EFFECTIVENESS AND COSTS OF PROSTAGLANDINS, WITH CAI OR AN ALPHA-2 AGONIST, IN THE TREATMENT OF GLAUCOMA-ANALYSIS CONDUCTED ON THE UK GENERAL PRACTITIONER RESEARCH DATABASE

    May 1, 2007, 00:00

  • PMC17 PRINCIPAL COMPONENT ANALYSIS OF A PATIENT SATISFACTION OF CARE SURVEY AND THE RELATIONSHIP BETWEEN PRINCIPAL COMPONENTS AND OVERALL SATISFACTION

    May 1, 2007, 00:00

  • PND5 DOES SPECIALTY CARE OF SPINA BIFIDA PATIENTS INFLUENCE COST OF CARE?

    May 1, 2007, 00:00

  • PMH41 RISPERIDONE LONG ACTING INJECTION (RLAI) IN THE TREATMENT OF EARLY VERSUS LATE DIAGNOSIS PATIENTS WITH SCHIZOPHRENIA- INTERIM RESULTS FROM OBSERVATIONAL STUDIES CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM

    May 1, 2007, 00:00

  • PCV36 THE EFFECT OF DRUG COST-SHARING ON ADHERENCE TO CHRONIC MEDICATIONS

    May 1, 2007, 00:00

  • PIN35 COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION IN HIGH-RISK INFANTS IN JAPAN

    May 1, 2007, 00:00

  • PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA

    May 1, 2007, 00:00

  • PCV22 A CARDIOVASCULAR DISEASE COST-EFFECTIVENESS MODEL BASED ON CTT META-ANALYSIS

    May 1, 2007, 00:00

  • PUK18 LINGUISTIC VALIDATION OF THE NOCTURIA QUALITY OF LIFE (N-QOL) QUESTIONNAIRE IN 10 LANGUAGES

    May 1, 2007, 00:00

  • PHP28 ASSESSING LEVELS OF ASSOCIATION BETWEEN HEALTH CARE EXPENDITURE AND HEALTH CARE INDICATORS IN ECONOMICALLY DEVELOPED COUNTRIES

    May 1, 2007, 00:00

  • MC3 CONTROLLING FOR COMORBIDITIES USING VARIATIONS OF THE CHARLSON COMORBIDITY INDEX ON MEDICARE CLAIMS DATA-THE CASE OF OVERACTIVE BLADDER

    May 1, 2007, 00:00

  • PCN24 CHARACTERIZING RESOURCE USE AND TREATMENT COSTS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE UNITED STATES (US)

    May 1, 2007, 00:00

  • PCN48 STANDARD GAMBLE TECHNIQUES FOR THE MEASUREMENT OF TREATMENT RELATED TOXICITY IN ONCOLOGY- APPLICATION TO ADVANCED STAGE PROSTATE CANCER

    May 1, 2007, 00:00

  • AR4 METHODS FOR MEASURING DOSE ESCALATION IN TNF ANTAGONISTS FOR RHEUMATOID ARTHRITIS PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE

    May 1, 2007, 00:00

  • PMH44 THE PREDICTIVE VALIDITY OF DIFFERENT ADHERENCE MEASURES USING ADMINISTRATIVE CLAIMS DATA

    May 1, 2007, 00:00

  • NE3 THE IMPORTANCE OF MODIFYING THE COURSE OF ALZHEIMER'S DISEASE- OLDER AMERICANS' RISK-BENEFIT PREFERENCES FOR NEW TREATMENTS

    May 1, 2007, 00:00

  • PAA10 ALLERGY IMMUNOTHERAPY- PATTERNS AND OUTCOMES OF CARE FOR ALLERGIC RHINITIS

    May 1, 2007, 00:00

  • PCV43 PREDICTORS OF CLOPIDOGREL THERAPY PERSISTENCE IN ACUTE CORONARY SYNDROME PATIENTS

    May 1, 2007, 00:00

  • PCV58 HOSPITAL POLICIES FOR TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE

    May 1, 2007, 00:00

  • PDB31 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PRIMARY CARE PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DEPRESSION

    May 1, 2007, 00:00

  • PCV64 FACTOR SCREENING FOR PARSIMONY OF VARIABLES IN PHARMACOECONOMIC MODELS

    May 1, 2007, 00:00

  • PND9 THE COST-EFFECTIVENESS OF NATALIZUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

    May 1, 2007, 00:00

  • PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND

    May 1, 2007, 00:00

  • PHP9 THE IMPACT OF MAIL ORDER PHARMACY IN DRUG UTILIZATION AND REIMBURSEMENT IN A LARGE RETIREMENT SYSTEM

    May 1, 2007, 00:00

  • POI3 A COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN SPINE FUSION SURGERY IN SWEDEN AND DENMARK

    May 1, 2007, 00:00

  • POI4 INPATIENT COSTS AND OUTCOMES ASSOCIATED WITH TRAUMATIC INJURY IN THE UNITED STATES BY INJURY SEVERITY AND TRAUMA CENTER DESIGNATION

    May 1, 2007, 00:00

  • PQ1 HOSPITAL COMPLIANCE WITH ACCP GUIDELINES FOR ANTICOAGULANT THERAPY AND JCAHO PERFORMANCE MEASURES

    May 1, 2007, 00:00

  • PSK3 THE DIRECT AND INDIRECT COST BURDEN ASSOCIATED WITH SEBORRHEIC DERMATITIS

    May 1, 2007, 00:00

  • PMC29 ICER VS. IERC-THEORETICAL HEALTH ECONOMICS VS. PRACTICAL DECISION MAKER BASED VALUE EVIDENCE

    May 1, 2007, 00:00

  • PPN10 COSTS ATTRIBUTABLE TO INTRAVENOUS PATIENT CONTROLLED ANALGESIA- FOCUS ON DEVICE-RELATED EVENTS

    May 1, 2007, 00:00

  • OB3 CORRELATION OF WEIGHT TO CARDIOMETABOLIC RISK AS IDENTIFIED BY ICD-9 DIAGNOSIS CODES AND PRESCRIPTIONS IN PRIMARY CARE

    May 1, 2007, 00:00

  • PIN30 SMOKING STATUS AND PNEUMONIA IMMUNIZATION- FINDINGS FROM THE 2005 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS) DATA

    May 1, 2007, 00:00

  • PDB18 THE RELATIVE COST EFFECTIVENESS OF INSULIN GLARGINE VERSUS NPH INSULIN USING UK REAL LIFE DATA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2007, 00:00

  • PPN15 EXAMINING FAMILY PHYSICIANS' ATTITUDES AND WILLINGNESS TO PRESCRIBE LONG-ACTING OPIOIDS TO PATIENTS WITH MODERATE TO SEVERE CHRONIC NONMALIGNANT PAIN

    May 1, 2007, 00:00

  • PR4 VALUING CHILDREN'S HEALTH FOR ECONOMIC EVALUATIONS-THEORETICAL AND METHODOLOGICAL CONSIDERATIONS

    May 1, 2007, 00:00

  • POI7 WOMEN ARE MORE PERSISTENT WITH MONTHLY IBANDRONATE VS.WEEKLY BISPHOSPHONATES- RESULTS FROM A RETROSPECTIVE DATABASE

    May 1, 2007, 00:00

  • PSK6 THE IMPACT OF PSORIASIS ON HEALTH CARE COSTS AND WORK LOSS

    May 1, 2007, 00:00

  • PDB23 IMPACT OF PATIENT EDUCATION ON HBA1C REDUCTION IN DIABETIC PATIENTS WITH CONCOMITANT HYPERTENSION

    May 1, 2007, 00:00

  • PIN14 A CANADIAN COST-EFFECTIVENESS ANALYSIS OF DARUNAVIR FOR HIV INFECTION IN TREATMENTEXPERIENCED ADULTS

    May 1, 2007, 00:00

  • PCN41 DRUG COST CONSIDERATIONS FOR ERYTHROPOIETIC STIMULATING THERAPIES (ESTS) AGENTS IN PATIENTS INITIATED AT FDA-APPROVED DOSING- RESULTS FROM PRACTICE PATTERNS IN A PROSPECTIVE OBSERVATIONAL STUDY

    May 1, 2007, 00:00

  • CV3 LONG-TERM HEALTH OUTCOMES FOR PATIENTS HOSPITALIZED WITH UNSTABLE ANGINA AND NSTEMI IN THE CALIFORNIA MEDICAID POPULATION-ASSESSMENT OF CLOPIDOGREL THERAPY IN ACS

    May 1, 2007, 00:00

  • IN2 MARKET STRUCTURE AND EFFECTIVENESS OF PRICE CONTROL FOR ANTIRETROVIRAL MEDICAMENTS IN COLOMBIA

    May 1, 2007, 00:00

  • PMC2 THE EFFECT OF PHARMACIST CONSULTATION ON PATIENT MEDICATION ADHERENCE-AN INSTRUMENTAL VARIABLE APPROACH

    May 1, 2007, 00:00

  • PIN27 USING DECISION SIMULATION MODEL TO EVALUATE THE COST EFFECTIVENESS OF ENTECAVIR COMPARED TO ADEFOVIR THERAPY IN LAMIVUDINE REFRACTORY CHRONIC HEPATITIS B (CHB) PATIENTS-ANALYSES FROM A US PAYER PERSPECTIVE

    May 1, 2007, 00:00

  • PHP30 ATTITUDES OF CHAIN PHARMACY PERSONNEL TOWARD E-PRESCRIBING

    May 1, 2007, 00:00

  • PHP27 HEALTH LOCUS OF CONTROL AND USE OF CONVENTIONAL AND ALTERNATIVE CARE- A COHORT STUDY

    May 1, 2007, 00:00

  • PND22 IMPLICATIONS OF COMORBIDITY ON COSTS FOR PATIENTS WITH ALZHEIMER'S DISEASE

    May 1, 2007, 00:00

  • PMC12 PRICE VS ACCESS-A PROBABILISTIC MODEL FOR GUIDING PRICING DECISIONS

    May 1, 2007, 00:00

  • PAA14 PRESCRIPTION DRUG INSURANCE COVERAGE- RISK FACTOR FOR EMERGENCY DEPARTMENT VISITS AND OVER UTILIZATION OF SHORT ACTING BRONCHODILATORS IN ASTHMA PATIENTS OF THE UNITED STATES

    May 1, 2007, 00:00

  • PDB7 BUDGET IMPACT ANALYSIS OF PIOGLITAZONE FOR DIABETES IN TAIWAN-A RETROSPECTIVE DATABASE ANALYSIS

    May 1, 2007, 00:00

  • PCN49 LINGUISTIC VALIDATION OF THE FACT-HEAD AND NECK IN 8 LANGUAGES FOR INDIA

    May 1, 2007, 00:00

  • PDB5 BODY WEIGHT GAIN EXPERIENCED BY DIABETIC PATIENTS DUE TO THIAZOLIDINEDIONES (TZDS)- META-ANALYSIS OF PUBLISHED RANDOMIZED SHORT-TERM CLINICAL TRIALS

    May 1, 2007, 00:00

  • PMC34 AN APPLICATION OF ITEM RESPONSE THEORY TO PRESCRIBERS' KNOWLEDGE AND ATTITUDE MEASUREMENT

    May 1, 2007, 00:00

  • PRS1 BURDEN OF CONCOMITANT ASTHMA AND COPD IN A MEDICAID POPULATION

    May 1, 2007, 00:00

  • PCV69 BLOOD PRESSURE SUCCESS ZONE LONGITUDINAL STUDY OF SUCCESS (BPSZ-BLISS). AN OBSERVATIONAL, MULTICENTER STUDY OF THE IMPACT OF THE BPSZ EDUCATIONAL PROGRAM ON BLOOD PRESSURE CONTROL, PERSISTENCE, COMPLIANCE, AND TREATMENT SATISFACTION. ...

    May 1, 2007, 00:00

  • PMH46 NOVEL USE OF A TELEPHONE BASED INTERACTIVE VOICE RESPONSE SYSTEM TO IMPROVE DATA COLLECTION

    May 1, 2007, 00:00

  • PEY5 A COST-BENEFIT ANALYSIS OF THE SN60WF ASPHERIC INTRAOCULAR LENS

    May 1, 2007, 00:00

  • PSM4 CONSUMER PERCEPTION OF SELF-AID MATERIALS IN OVERTHE- COUNTER NICOTINE PATCH

    May 1, 2007, 00:00

  • PHP46 THE RELATIVE PERFORMANCE OF PHARMACEUTICAL SECTOR SECURITY PRICES DURING STOCK MARKET CRASHES

    May 1, 2007, 00:00

  • DISCLOSURE INFORMATION

    May 1, 2007, 00:00

  • PUK19 LINGUISTIC VALIDATION OF THE ICIQ MALE SEXUAL MATTERS ASSOCIATED WITH LOWER URINARY TRACT SYMPTOMS QUESTIONNAIRE (ICIQ-MLUTSSEX) IN 7 LANGUAGES

    May 1, 2007, 00:00

  • PCV62 ASSESSING SYSTEMATIC DIFFERENCES IN PHYSICIAN'S TENDENCY TO REPORT ROUNDED BLOOD PRESSURE MEASUREMENTS

    May 1, 2007, 00:00

  • IN1 COST-EFFECTIVENESS ANALYSIS OF DARUNAVIR/R FOR HIV INFECTION IN TREATMENT-EXPERIENCED ADULTS IN THE US- UNDERSTANDING THE UNCERTAINTY IN THE ESTIMATES

    May 1, 2007, 00:00

  • AO1 MEDICATION COMPLIANCE TO STATIN THERAPY AND ITS IMPACT ON DISEASE OUTCOMES IN TYPE 2 DIABETES

    May 1, 2007, 00:00

  • RS4 IMPACT OF EARLY INITIATION OF INHALED CORTICOSTEROIDS ON RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH COPD- A PROPENSITY SCORE MATCHING APPROACH

    May 1, 2007, 00:00

  • PCV51 PROCEDURAL MIX AND VOLUME DURING THE FIRST YEAR OF OWNERSHIP OF A COMPUTED TOMOGRAPHY ANGIOGRAPHY SCANNER- EVIDENCE FROM A LARGE CARDIOLOGY PRACTICE

    May 1, 2007, 00:00

  • PCV42 USE OF RECOMMENDED MEDICATIONS AFTER MYOCARDIAL INFARCTION IN AUSTRIA

    May 1, 2007, 00:00

  • PMH35 TREATMENT INITIATION WITH ATOMOXETINE VS. STIMULANTS FOR ADULTS WITH ADHD IN MEDICAID SETTINGS

    May 1, 2007, 00:00

  • Eliciting Expert Opinion for Economic Models- An Applied Example

    May 1, 2007, 00:00

  • PMH39 A MULTI-DOMAIN MICRO-SIMULATION ECONOMIC MODELING FRAMEWORK IN ALZHEIMER'S DISEASE

    May 1, 2007, 00:00

  • PMH45 SOCIODEMOGRAPHIC AND CLINICAL CORRELATES OF UTILITY SCORES IN ALZHEIMERS DISEASE

    May 1, 2007, 00:00

  • PCASE12 DETERMINING THE VALUE OF DIAGNOSTIC/GENETIC TESTING TO INFORM HEALTH PLAN DECISION MAKING- ONCOTYPE DX AS A CASE STUDY

    May 1, 2007, 00:00

  • POI2 KAPLAN-MEIER SURVIVAL ANALYSIS OF PATIENTS WITH DISPLACED AND NON-DISPLACED FEMORAL NECK FRACTURE OVER 60

    May 1, 2007, 00:00

  • PMC36 SIX SIGMA AND LEAN INTEGRATED METHODOLOGIES IN HEALTH CARE TO IMPROVE PATIENT QUALITY OF LIFE

    May 1, 2007, 00:00

  • PDB1 RECENT TRENDS IN OBESITY-RELATED CO-MORBIDITIES AND MEDICAL COSTS IN THE US

    May 1, 2007, 00:00

  • PQ4 EVALUATION OF A MULTICENTER AND MULTIDISCIPLINARY CONGESTIVE HEART FAILURE MANAGEMENT PROGRAM

    May 1, 2007, 00:00

  • PAR13 TUMOR NECROSIS FACTOR INHIBITORS— A PHARMACOECONOMIC REVIEW OF ITS USE IN ANKYLOSING SPONDYLITIS

    May 1, 2007, 00:00

  • PND14 ECONOMIC CONSEQUENCES OF THERAPEUTIC ALTERATION IN THE MANAGEMENT OF INSOMNIA

    May 1, 2007, 00:00

  • MC1 METHODS OF MODEL CALIBRATION-A COMPARATIVE APPROACH

    May 1, 2007, 00:00

  • PST3 THE IMPACT OF WIDESPREAD ACCESS TO ORGANIZED STROKE CARE IN CANADA

    May 1, 2007, 00:00

  • PHP3 PRESCRIPTION DRUG COST-SHARING AMONG COMMERCIALLY-INSURED CHILDREN AND ADULTS WITH CHRONIC ILLNESS

    May 1, 2007, 00:00

  • PHP16 COMPARING GENERIC DISPENSING RATES AMONG THREE DIFFERENT RETAIL CHANNELS

    May 1, 2007, 00:00

  • PIH8 MEDICARE PART D AND STATE-LEVEL VARIATIONS IN MEDICARE ADVANTAGE PARTICIPATION

    May 1, 2007, 00:00

  • PCN23 IDENTIFICATION OF PATIENTS WITH SMALL CELL LUNG CANCER (SCLC) AND COST ASSESSMENT OF INTRAVENOUS (IV) CHEMOTHERAPY IN CLAIMS DATA

    May 1, 2007, 00:00

  • PCASE9 MANAGEMENT OF INAPPROPRIATE USE OF GROWTH HORMONE

    May 1, 2007, 00:00

  • PHP1 MEDICATION SAFETY IN COMMUNITY PHARMACY- IMPACT OF SOCIOTECHNICAL FACTORS ON DISPENSING ERRORS

    May 1, 2007, 00:00

  • CN2 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF STAGE III COLON CANCER IN TAIWAN

    May 1, 2007, 00:00

  • PMH9 NET BENEFIT ANALYSIS OF DIVALPROEX SODIUM EXTENDED-RELEASE COMPARED TO VALPROIC ACID IN THE TREATMENT OF BIPOLAR DISORDER

    May 1, 2007, 00:00

  • PCV10 CLINICAL OUTCOME OF HYPERTENSION MANAGEMENT- A FIVE YEAR OBSERVATIONAL STUDY

    May 1, 2007, 00:00

  • PCV19 COST COMPARISON OF DIFFERENT TREATMENTS FOR DEEP VEIN THROMBOSIS PROPHYLAXIS DURING ABDOMINAL SURGERY

    May 1, 2007, 00:00

  • PAR19 ARTHRITIS AND HEALTH-RELATED QUALITY OF LIFE AMONG ADULTS IN OHIO

    May 1, 2007, 00:00

  • PAR1 MORTALITY RATE OF PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIASIS, CROHN'S DISEASE AND ULCERATIVE COLITIS IN THE UNITED KINGDOM

    May 1, 2007, 00:00

  • PAR17 A COMPARISION OF THERAPEUTIC PERSISTENCE AMONG ANTI-TUMOR NECROSIS FACTORS (ANTI-TNFS) IN THE TREATMENT OF RHEUMATOID ARTHRITIS

    May 1, 2007, 00:00

  • AO2 THE ASSOCIATION BETWEEN THERAPEUTIC PERSISTENCE AND NON-PHARMACY COST AMONG ANTI-TUMOR NECROSIS FACTORS (ANTI-TNFS) IN THE TREATMENT OF RHEUMATOID ARTHRITIS

    May 1, 2007, 00:00

  • CS1 EPOETIN ALFA AND DARBEPOETIN ALFA DOSING TRENDS AND DRUG COSTS IN ELDERLY PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS

    May 1, 2007, 00:00

  • PST2 HOSPITAL-BASED OUTCOMES ASSOCIATED WITH NONTRAUMATIC SUBARACHNOID HEMORRHAGE

    May 1, 2007, 00:00

  • PMC21 FEASIBILITY, VALIDITY AND RELIABILITY OF THE WELSH VERSION OF THE EQ-5D HEALTH STATUS QUESTIONNAIRE

    May 1, 2007, 00:00

  • WH1 BREAST CANCER PATIENTS' PREFERENCES FOR LOCAL AND SYSTEMIC THERAPY

    May 1, 2007, 00:00

  • PHP2 WASTE OF DRUGS IN TURKEY

    May 1, 2007, 00:00

  • PRS7 COMPARISON OF EVENTS (HOSPITALIZATIONS AND EMERGENCY DEPARTMENT VISITS) AND COSTS FOR MEDICAID PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY INITIAL MEDICATION REGIMEN

    May 1, 2007, 00:00

  • PCV4 CUMULATIVE PERSISTENCE OF ANTIHYPERTENSIVE MEDICATION AS A NEWLY PRESCRIBED DRUG IN A MEDICAID POPULATION

    May 1, 2007, 00:00

  • PSK4 FREQUENCY AND COST CONSEQUENCES ASSOCIATED WITH FAILURE OF MUPIROCIN AMONG UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS (USSSI)

    May 1, 2007, 00:00

  • PMH19 A COMPARISON OF TOTAL DIRECT MEDICAL COSTS TO MANAGED CARE OF ESCITALOPRAM VERSUS VENLAFAXINE XR TREATMENT IN MAJOR DEPRESSIVE DISORDER

    May 1, 2007, 00:00

  • WH2 STANDARD GAMBLE TECHNIQUES FOR THE MEASUREMENT OF TREATMENT RELATED TOXICITY IN ONCOLOGY- APPLICATION TO BREAST CANCER

    May 1, 2007, 00:00

  • PCN27 AN ANALYSIS OF COSTS ASSOCIATED WITH ADMINISTRATION OF TRASTUZUMAB-BASED COMBINATION IV THERAPIES IN METASTATIC BREAST CANCER PATIENTS IN A US POPULATION

    May 1, 2007, 00:00

  • PIH6 CONTRACEPTIVE AND NON-CONTRACEPTIVE BENEFITS OF A LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN A VERTICALLY INTEGRATED HMO

    May 1, 2007, 00:00

  • PIH11 QUALITY-OF-LIFE WEIGHTS FOR THE U.S. POPULATION- SELF-REPORTED HEALTH STATUS AND PRIORITY HEALTH CONDITIONS, BY DEMOGRAPHIC CHARACTERISTICS

    May 1, 2007, 00:00

  • PHP38 SAME-DAY DISCHARGES FROM THE HOSPITAL TO THE HOME- IMPLICATIONS OF THE LACK OF A SHORT-STAY UNIT IN THE EMERGENCY ROOM

    May 1, 2007, 00:00

  • PCN19 TREND ANALYSIS OF UTILIZATION AND MARKET-SHARE COMPETITION FOR BREAST CANCER MEDICATIONS IN US MEDICAID PROGRAMS FROM 1991 TO 2005

    May 1, 2007, 00:00

  • PHP5 WILLING TO WAIT-THE INFLUENCE OF PHYSICIAN WAITING TIMES ON SATISFACTION WITH CARE

    May 1, 2007, 00:00

  • PCN31 SYSTEMATIC REVIEW OF TREATMENTS/INTERVENTIONS AND QALY IN BREAST CANCER PATIENTS

    May 1, 2007, 00:00

  • PIN33 ESTIMATING THE GDP SAVED DUE TO AIDS TREATMENT

    May 1, 2007, 00:00

  • PUK9 A RETROSPECTIVE MATCHED COHORT STUDY OF THE BURDEN OF SECONDARY HYPERPARATHYROIDISM (SHPT) IN PREDIALYSIS PATIENTS WITHOUT VITAMIN D RECEPTOR (VDR) ACTIVATOR THERAPY

    May 1, 2007, 00:00

  • PCV73 DESCRIBING DRUG USE PATTERNS USING SEQUENCE ANALYSIS

    May 1, 2007, 00:00

  • PCN37 FREQUENCY AND DISTRIBUTION OF CERVICAL SCREENING SMEARS IN HUNGARY

    May 1, 2007, 00:00

  • PMH11 MEDICATION USE PATTERNS AND COSTS ASSOCIATED WITH ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF BIPOLAR DISORDER

    May 1, 2007, 00:00

  • PGI15 MENTAL AND PHYSICAL FUNCTIONING REDUCED AMONG PATIENTS WITH FREQUENT ATYPICAL GERD SYMPTOMS

    May 1, 2007, 00:00

  • PMH31 DRUG COST DEVELOPMENT OF CITALOPRAM AND FLUOXETINE FOLLOWING THE INTRODUCTION OF GENERIC SUBSTITUTION IN FINLAND

    May 1, 2007, 00:00

  • CS3 HEALTH CARE EXPENDITURE AND PATIENT SATISFACTION- COST AND QUALITY FROM HEALTH CARE CONSUMERS' PERSPECTIVE

    May 1, 2007, 00:00

  • PAA5 ECONOMIC EVALUATION OF SYMBICORT® (BUDESONIDE/FORMOTEROL) MAINTENANCE AND RELIEVER THERAPY IN ASTHMA (SMART) COMPARED TO FIXED DOSE COMBINATION STRATEGIES

    May 1, 2007, 00:00

  • PHP23 A NATIONAL SURVEY ON PRESCRIBERS' KNOWLEDGE OF AND THEIR SOURCE OF DRUG-DRUG INTERACTION INFORMATION

    May 1, 2007, 00:00

  • PIN28 BUDGET IMPACT AND UTILISATION OF ANTIBIOTICS WITHIN SLOVAKIA

    May 1, 2007, 00:00

  • PPN9 COSTS AND COMORBIDITIES IN LOWER BACK PAIN PATIENTS USING NARCOTIC MEDICATIONS

    May 1, 2007, 00:00

  • PCV1 COMPARING THE RISKS OF DEVELOPING STROKE IN UNCOMPLICATED HYPERTENSIVE PATIENTS TREATED WITH DIFFERENT ANTI-HYPERTENSIVE DRUGS

    May 1, 2007, 00:00

  • PMH12 DEPRESSED INDIVIDUALS WITH MUSCULOSKELETAL CHRONIC PAIN AND HEADACHE SHOW HIGHER HEALTH CARE UTILIZATION AND COSTS

    May 1, 2007, 00:00

  • PCASE11 SYNAGIS 2005–2006 SEASON

    May 1, 2007, 00:00

  • MH3 PREVALENCE OF LIVER DISEASES IN MEDICAID RECIPIENTS WITH SCHIZOPHRENIA

    May 1, 2007, 00:00

  • PCV7 RELATIONSHIPS BETWEEN VENOUS THROMBOEMBOLIC (VTE) PROPHYLACTIC TREATMENTS AND VTE COMPLICATIONS OR THROMBOCYTOPENIA AND AMONG VETERANS RECEIVING TOTAL HIP REPLACEMENTS

    May 1, 2007, 00:00

  • PSU1 COST OF COMPLICATIONS ASSOCIATED WITH TOTAL KNEE REPLACEMENT AND TOTAL HIP REPLACEMENT

    May 1, 2007, 00:00

  • PMC10 RELIABILITY AND COMPLETENESS OF MEDICAID ENROLLMENT DATA-A COMPARATIVE ASSESSMENT OF SIX STATES

    May 1, 2007, 00:00

  • PMC11 APPLICATION OF ZERO INFLATED POISSON MODEL FOR ESTIMATING FUNCTIONS OF COST AND EFFECTIVENESS IN COUNT DATA

    May 1, 2007, 00:00

  • PCV23 EVALUATION OF DYSLIPIDEMIA THERAPIES FOR TREATMENT OF LOW HDL AND HIGH LDL-A COST-EFFECTIVENESS ANALYSIS BASED ON NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY III

    May 1, 2007, 00:00

  • PEY17 MULTIPLE METHODS TO ESTIMATE THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE OF THE OCULAR SURFACE DISEASE INDEX®

    May 1, 2007, 00:00

  • PCV56 THE COST-EFFECTIVENESS LANDSCAPE OF GENETIC TESTING WITH WARFARIN THERAPY

    May 1, 2007, 00:00

  • PMH20 THE ECONOMIC COSTS TO MANAGED CARE ORGANIZATIONS OF EXCESS MD WITHDRAWAL FROM DULOXETINE TREATMENT- AN OPPORTUNITY COSTS MODEL

    May 1, 2007, 00:00

  • PDB16 EMERGENCY ROOM CARE FOR DIABETES MELLITUS IN THE UNITED STATES- HOW MUCH DOES IT COST?

    May 1, 2007, 00:00

  • PEY1 COMPARISON OF TOPICAL CIPROFLOXACIN/DEXAMETHASONE OTIC SUSPENSION VERSUS POLYMYXIN B/NEOMYCIN/HYDROCORTISONE OTIC SUSPENSION FOR THE TREATMENT OF ACUTE OTITIS EXTERNA

    May 1, 2007, 00:00

  • PGI4 INCLUSION OF A PENTAVALENT ROTAVIRUS VACCINE IN THE NEW ZEALAND CHILDHOOD IMMUNISATION SCHEDULE

    May 1, 2007, 00:00

  • PHM3 ANEMIA IN LONG-TERM CARE PATIENTS- PREVALENCE AND RELATIONSHIP TO FALLS

    May 1, 2007, 00:00

  • PCASE4 DIVERSITY OF ANTIBIOTIC USE AND BACTERIAL RESISTANCE

    May 1, 2007, 00:00

  • PIN11 COST-EFFECTIVENESS OF SUBSTITUTING LAMIVUDINE (LVD) WITH ENTECAVIR (ETV) IN CHRONIC HEPATITIS B (CHB) PATIENTS IN THE PUBLIC SECTOR OF HONG KONG

    May 1, 2007, 00:00

  • PMH18 INCREMENTAL MEDICAID EXPENDITURES ASSOCIATED WITH DEMENTIA

    May 1, 2007, 00:00

  • AR1 COST-EFFECTIVENESS OF ETANERCEPT AND INFLIXIMAB IN THE REAL-WORLD SETTING—AN ESTIMATE BASED ON PUBLISHED GERMAN DATA ON RESPONSE AND ADHERENCE

    May 1, 2007, 00:00

  • PCV63 DYNAMIC OPTIMIZATION IN THE TREATMENT OF HYPERLIPIDEMIA

    May 1, 2007, 00:00

  • PUK14 ANEMIA-RELATED TREATMENT VARIATIONS IN WOMEN WITH CHRONIC KIDNEY DISEASE IN US OUTPATIENT SETTINGS

    May 1, 2007, 00:00

  • PMH38 ASSESSING PERSISTENCE OF ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA- USING THE DATA FROM PENNSYLVANIA MEDICAID TO UNDERSTAND THE CHALLENGES

    May 1, 2007, 00:00

  • PCV30 COST-EFFECTIVENESS AMONG BRAND AND GENERIC STATINS BASED ON REAL-WORLD EFFECTIVENESS- IMPLICATIONS FOR STATIN FORMULARY DESIGN

    May 1, 2007, 00:00

  • PAA16 PREDICTORS OF THE PRESCRIBING OF ASTHMA PHARMACOTHERAPY IN THE AMBULATORY PATIENT POPULATION OF THE UNITED STATES

    May 1, 2007, 00:00

  • PCV20 A COST-EFFECTIVENESS STUDY COMPARING IVABRADINE WITH STANDARD CARE IN STABLE ANGINA PECTORIS IN THE NETHERLANDS

    May 1, 2007, 00:00

  • PHP4 FACTORS INFLUENCING USER CHOICES TO VISIT EITHER GENERAL PRACTITIONERS OR COMMUNITY PHARMACISTS FOR MINOR AILMENTS—A DISCRETE CHOICE EXPERIMENT

    May 1, 2007, 00:00

  • PND30 COMORBIDITIES, ECONOMIC AND HUMANISTIC FACTORS ASSOCIATED WITH MIGRAINE-A PROPENSITY SCORE ANALYSIS OF NATIONAL SURVEY DATA

    May 1, 2007, 00:00

  • PUK8 COST EFFECTIVENESS OF ICODEXTRINE-BASED SOLUTIONS IN END STAGE RENAL DISEASE PATIENTS UNDERGOING PERITONEAL DIALYSIS THERAPY

    May 1, 2007, 00:00

  • PMH34 PHARMACOLOGIC TREATMENT OF GENERALIZED ANXIETY DISORDER WITH COMORBID DEPRESSION AND PAIN CONDITIONS

    May 1, 2007, 00:00

  • PHP15 STUDYING THE IMPACT OF CO-PAYMENT DIFFERENTIAL ON GENERIC DISPENSING RATE IN A MANAGED CARE POPULATION

    May 1, 2007, 00:00

  • A Systematic Review Evaluating Health-Related Quality of Life, Work Impairment, and Health-Care Costs and Utilization in Abnormal Uterine Bleeding

    May 1, 2007, 00:00

  • DB3 TREATMENT EFFECT ESTIMATION-A COMPARISON BETWEEN RANDOMIZED CONTROLLED TRIALS AND OBSERVATIONAL STUDY WITH THREE DIFFERENT CAUSAL EFFECT METHODS-PROPENSITY SCORE, MARGINAL STRUCTURE MODEL AND DOUBLY ROBUST METHODS

    May 1, 2007, 00:00

  • PRS2 CLINICAL OUTCOMES OF PATIENTS HOSPITALIZED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATIONS IN SINGAPORE

    May 1, 2007, 00:00

  • PND24 MEDICATION SIDE-EFFECTS AND ADHERENCE AMONG PATIENTS WITH MULTIPLE SCLEROSIS

    May 1, 2007, 00:00

  • PIH5 SURGICAL COST OF PELVIC ORGAN PROLAPSE IN GERMANY, FRANCE AND ENGLAND

    May 1, 2007, 00:00

  • MD1 WHAT IF THE FEDERAL SUPPLY SCHEDULE SET PHARMACEUTICAL PRICES FOR SENIORS?

    May 1, 2007, 00:00

  • PND1 ASSESSING THE NET CLINICAL BENEFIT AND ABSOLUTE RISK REDUCTION OF DISEASE MODIFYING DRUGS IN RELAPSING REMITTING MULTIPLE SCLEROSIS

    May 1, 2007, 00:00

  • PMH22 HEALTH CARE COSTS AND RESOURCE USE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER-A COMPARISON BETWEEN ESCITALOPRAM AND OTHER ANTIDEPRESSANTS

    May 1, 2007, 00:00

  • PND28 PSYCHOMETRIC EVALUATION OF OBSTRUCTIVE SLEEP APNEA SPECIFIC HEALTH RELATED QUALITY OF LIFE INSTRUMENTS

    May 1, 2007, 00:00

  • PMC28 JUSTIFYING THE USE OF COST MINIMIZATION ANALYSIS- REPORTING COMPARATORS' EQUIVALENCE

    May 1, 2007, 00:00

  • PGI11 RELATIONSHIP BETWEEN GASTROESOPHAGEAL REFLUX DISEASE SYMPTOMS AND COSTS-A DATABASE STUDY IN A US COHORT

    May 1, 2007, 00:00

  • PHP8 RACIAL/ETHNIC DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AND OUT-OF-POCKET COSTS

    May 1, 2007, 00:00

  • PHP12 DIFFERENCES IN CHRONIC DISEASE CARE OF PRE_MEDICARE INDIVIDUALS BETWEEN METROPOLITAN AND NON-METROPOLITAN SETTINGS

    May 1, 2007, 00:00

  • PIN23 DETERMINANTS OF TOTAL HOSPITAL COSTS AMONG INPATIENTS WITH CANDIDEMIA

    May 1, 2007, 00:00

  • PAA8 QUALITY-ADJUSTED LENGTH OF STAY ANALYSIS OF HOSPITALIZED PATIENTS WITH ASTHMA OR COPD TREATED WITH LEVALBUTEROL OR RACEMIC ALBUTEROL

    May 1, 2007, 00:00

  • PIN8 BURDEN OF HERPES ZOSTER AND HEALTH AND BUDGET IMPACT OF A VACCINATION PROGRAM

    May 1, 2007, 00:00

  • DB2 RACIAL DIFFERENCES IN EMERGENCY ROOM VISITS ASSOCIATED WITH MEDICATION USE IN MEDICAID ENROLLEES WITH TYPE 2 DIABETES

    May 1, 2007, 00:00

  • PCV6 NON-PERSISTENT USE OF ANTIHYPERTENSIVE DRUGS INCREASES RISK OF HOSPITALIZATIONS FOR ACUTE MYOCARDIAL INFARCTION BY 10% IN PATIENTS WITH LOW OR INTERMEDIATE CARDIOVASCULAR RISK

    May 1, 2007, 00:00

  • PCV18 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS- A COST-EFFECTIVENESS ANALYSIS COMPARING MAGNETIC RESONANCE ANGIOGRAPHY WITH DIGITAL SUBTRACTION ANGIOGRAPHY

    May 1, 2007, 00:00

  • PCN57 PATIENT REPORTED OUTCOMES IN LABELING FOR ONCOLOGY PRODUCTS- REVIEW OF FDA AND EMEA LABELS

    May 1, 2007, 00:00

  • PAR12 INCREASE IN ECONOMIC BURDEN OF HIP AND KNEE REPLACEMENTS IN THE UNITED STATES- ESTIMATED FROM THE HEALTH CARE COST AND UTILIZATION PROJECT— NATIONAL INPATIENT SURVEY

    May 1, 2007, 00:00

  • PMH36 DISEASE PROGRESSION IN ALZHEIMER'S DISEASE PATIENTS TREATED WITH A CHOLINESTERASE INHIBITOR IN CLINICAL PRACTICE

    May 1, 2007, 00:00

  • PDB33 VALIDATION OF THE 25-ITEM NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE (VFQ-25) IN PATIENTS WITH DIABETIC RETINOPATHY

    May 1, 2007, 00:00

  • PHP42 CORRELATION BETWEEN COLLEGE STUDENT ACTIVITIES AND TWO PRODUCTIVITY MEASUREMENTS

    May 1, 2007, 00:00

  • PAA22 CAN PATIENTS WITH ASTHMA FEEL THEIR MAINTENANCE INHALER WORKING RIGHT AWAY? REPRODUCIBILITY AND VALIDITY OF A WEEKLY DIARY FOR ASSESSING PERCEPTION AND SATISFACTION

    May 1, 2007, 00:00

  • PMH5 A COMPARISON OF TREATMENT-EMERGENT DIABETES AMONG ATYPICAL AND TYPICAL ANTIPSYCHOTIC USERS- USING A BIVARIATE PROBIT MODEL

    May 1, 2007, 00:00

  • PIN25 DIRECT COSTS OF ANEMIA AMONG PATIENTS TREATED WITH ZIDOVUDINE

    May 1, 2007, 00:00

  • PND16 ASSOCIATION OF LONG-TERM MIGRAINE PREVENTIVE MEDICATION USE AND RESOURCE UTILIZATION/PRODUCTIVITY LOSS- RESULTS FROM THE AMERICAN MIGRAINE PREVALENCE AND PREVENTION (AMPP) STUDY

    May 1, 2007, 00:00

  • PCASE10 SHOULD GENETIC TESTING BE USED TO GUIDE WARFARIN THERAPY?

    May 1, 2007, 00:00

  • PCV41 UTILIZATION AND COMPLIANCE OF CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF HYPERTENSION IN THE LOUISIANA MEDICAID PROGRAM

    May 1, 2007, 00:00

  • PIN1 COST-EFFECTIVENESS OF ACUTE AND CHRONIC RHINOSINUSITIS AT THE MEXICAN INSTITUTE OF SOCIAL SECURITY (IMSS)

    May 1, 2007, 00:00
  • «
  • 151
  • 152
  • 153
  • 154
  • 155 (current)
  • 156
  • 157
  • 158
  • 159
  • 160
  • »